Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar

BACKGROUND: Plasmodium falciparum resistance to artemisinins, the first line treatment for malaria worldwide, has been reported in western Cambodia. Resistance is characterized by significantly delayed clearance of parasites following artemisinin treatment. Artemisinin resistance has not previously...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Kyaw, M, Nyunt, M, Chit, K, Aye, M, Aye, K, Lindegardh, N, Tarning, J, Imwong, M, Jacob, C, Rasmussen, C, Perin, J, Ringwald, P
التنسيق:	Journal article
اللغة:	English
منشور في:	Public Library of Science 2013

مواد مشابهة

Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar.
حسب: Myat P Kyaw, وآخرون
منشور في: (2013-01-01)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
حسب: Das, J, وآخرون
منشور في: (2018)

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
حسب: Jesmin Permala Lohy Das, وآخرون
منشور في: (2018-03-01)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam
حسب: Hien, T, وآخرون
منشور في: (2012)

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam.
حسب: Hien, T, وآخرون
منشور في: (2012)

Characterization of Trichoderma species Isolated from Different Ecosystems in Myanmar
حسب: Khin Maung Nyunt, وآخرون
منشور في: (2020-03-01)

Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
حسب: Than Naing Soe, وآخرون
منشور في: (2017-07-01)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
حسب: Smithuis, F, وآخرون
منشور في: (2006)

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.
حسب: Htun, M, وآخرون
منشور في: (2017)

<it>In vivo</it> susceptibility of <it>Plasmodium falciparum</it> to artesunate in Binh Phuoc Province, Vietnam
حسب: Hien Tran, وآخرون
منشور في: (2012-10-01)

Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)
حسب: Myat Htut Nyunt, وآخرون
منشور في: (2017-08-01)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
حسب: Win, AA, وآخرون
منشور في: (2016)

Seroprevalence of toxoplasmosis among reproductive-aged women in Myanmar and evaluation of luciferase immunoprecipitation system assay
حسب: Khin Myo Aye, وآخرون
منشور في: (2020-11-01)

The legend of laphet: A Myanmar fermented tea leaf
حسب: Thazin Han, وآخرون
منشور في: (2015-12-01)

Overview of pediatric oncology and hematology in Myanmar
حسب: Jay Halbert, وآخرون
منشور في: (2014-01-01)

Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria.
حسب: Das, D, وآخرون
منشور في: (2013)

Myanmar in Asean : Myanmar-Asean cooperation for development.
حسب: Hnin Hnin Aye.
منشور في: (2008)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
حسب: Jamsen, K, وآخرون
منشور في: (2011)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
حسب: Thu Zar Han, وآخرون
منشور في: (2017-08-01)

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.
حسب: Valea, I, وآخرون
منشور في: (2014)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
حسب: Fang Huang, وآخرون
منشور في: (2020-09-01)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
حسب: Awab, GR, وآخرون
منشور في: (2016)

Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
حسب: Smithuis, F, وآخرون
منشور في: (2004)

Comparison of microscopy and PCR for the detection of human Plasmodium species and Plasmodium knowlesi in southern Myanmar
حسب: Han, T.Z., وآخرون
منشور في: (2017)

Residual malaria among migrant workers in Myanmar: why still persistent and how to eliminate it?
حسب: Myat Htut Nyunt, وآخرون
منشور في: (2021-11-01)

Artemisinin resistance in Plasmodium falciparum malaria.
حسب: Dondorp, A, وآخرون
منشور في: (2009)

Spectrum of Upper Gastrointestinal Diseases in Patients Presenting with Dyspepsia—A First Report from Myanmar
حسب: Than Than Aye, وآخرون
منشور في: (2025-02-01)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
حسب: Lindegardh Niklas, وآخرون
منشور في: (2011-07-01)

Women's intergenerational intimate partner violence and household child abuse in Burma (Myanmar)
حسب: Stephanie Spaid Miedema, وآخرون
منشور في: (2022-03-01)

Attrition among HIV positive children enrolled under integrated HIV care programme in Myanmar: 12 years cohort analysis
حسب: Aung Chan Minn, وآخرون
منشور في: (2018-01-01)

Myanmar Number Normalization for Text-to-Speech
حسب: Aye Mya Hlaing, وآخرون
منشور في: (2022-08-01)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
حسب: Mcgready, R, وآخرون
منشور في: (2008)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated <it>Plasmodium falciparum </it>malaria
حسب: Singhasivanon Pratap, وآخرون
منشور في: (2009-09-01)

391 Health status of children with down syndrome in Myanmar
حسب: Kyaw Linn, وآخرون
منشور في: (2021-04-01)

Active surveillance for congenital rubella syndrome in Yangon, Myanmar
حسب: Thant Kyaw-Zin, وآخرون
منشور في: (2006-01-01)

Distribution of hepatitis B virus genotypes in the general population of Myanmar via nationwide study
حسب: Yi Yi Kyaw, وآخرون
منشور في: (2020-07-01)

Malaria incidence in Myanmar 2005–2014: steady but fragile progress towards elimination
حسب: Thet Thet Mu, وآخرون
منشور في: (2016-10-01)

The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.
حسب: Ambler, M, وآخرون
منشور في: (2009)

Detection of I491F and V170F rpoB mutations associated with misdiagnosis of rifampicin resistance among patients with drug-susceptible tuberculosis treatment failure, Myanmar, 2022
حسب: Phyu Win Ei, وآخرون
منشور في: (2025-03-01)

Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar.
حسب: Guthmann, J, وآخرون
منشور في: (2008)